DrugDashboards
← Home
Manufacturing facility

Eugia Pharma Specialities Limited

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
India
Registered address
Unit-III, Plot No: 4, 34 to 40, 41P, 44 to 48, EPIP, TSIIC, IDA, Pashamylaram Village, Patancheru Mandal, Sangareddy, Telangana 502307, India (IND)
Operations here
analysismanufacturepack
FDA identifiers
FEI 3008461619 · DUNS 650498244

Recent inspection flagged official action

FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 93 drugs, 11 already in shortage. A supply problem here can ripple to all of them.

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • OAIDrug Quality Assurance2026-02-06
  • OAIDrug Quality Assurance2024-02-02
  • VAIDrug Quality Assurance2018-12-14
  • VAIDrug Quality Assurance2018-02-20
  • VAIDrug Quality Assurance2016-09-16
  • VAIDrug Quality Assurance2014-09-26
  • NAIDrug Quality Assurance2012-09-12

Drugs this plant is listed as making

93 distinct drugs across 184 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.